Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
Initial Presentation and Management of Hilar and Peripheral Cholangiocarcinoma: Is a Node-Positive Status or Potential Margin-Positive Result a Contraindication to Resection
Annals of Surgical Oncology, 09/30/09
Nguyen KT et al. – Survival benefits can be achieved with resection for cholangiocarcinoma. Given the lack of effective alternative therapy, when confronted with the potential risk of positive margins or isolated nodal disease, the authors continue to advocate aggressive surgical resection for both hilar and peripheral CC with the ultimate goal of negative margin resection.
Related Articles
Surgical Management of Infrahilar/Suprapancreatic Cholangiocarcinoma: an Analysis of the Surgical Procedures, Surgical Margins, and Survivals of 77 Patients
Journal of Gastrointestinal Surgery, 11/13/09
Relevance Score: 87%
CD10+ fibroblasts are more involved in the progression of hilarextrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma
Histopathology, 10/15/09
Relevance Score: 87%
Repetitive response to gemcitabine that led to curative resection in cholangiocarcinoma
World Journal of Gastroenterology, 10/07/09
Relevance Score: 87%
Surgical treatment of hilar cholangiocarcinoma in the new era
Journal of Hepato-Biliary-Pancreatic Surgery, 10/27/09
Relevance Score: 85%
Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality
Journal of Hepato-Biliary-Pancreatic Surgery, 10/13/09
Relevance Score: 85%
Today in Hepatobiliary/Pancreas...keeping you current
Receive free subspecialty "5-minute updates" via email
Single HCC smaller than 2 cm: surgery or ablation
Journal of Hepato-Biliary-Pancreatic Surgery, 11/25/09
One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008
Journal of Hepato-Biliary-Pancreatic Surgery, 11/25/09
Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma
Journal of Surgical Oncology, 11/25/09
Today in Patient Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Impact of Palliative Chemotherapy and Surgery on Management of Stage IV Incurable Colorectal Cancer
Annals of Surgical Oncology, 11/25/09
Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience
Annals of Surgical Oncology, 11/23/09
Role of Computed Tomography in the Surgical Management of Patients with Bowel Obstruction Secondary to Recurrent Ovarian Carcinoma
Annals of Surgical Oncology, 11/23/09
Today in Surgical Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Impact of Palliative Chemotherapy and Surgery on Management of Stage IV Incurable Colorectal Cancer
Annals of Surgical Oncology, 11/25/09
Excision of axillary lymph node recurrences in breast cancer patients with axillary ROLL
Journal of Surgical Oncology, 11/25/09
Single HCC smaller than 2 cm: surgery or ablation
Journal of Hepato-Biliary-Pancreatic Surgery, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


